Vetnostrum Animal Health Co., Ltd. (6936.TW) stock: key figures, P/E, revenue and dividend

Consumer Staples · Taiwan

Price
32.05 TWD
Market cap
2.33 bn TWD
P/E (2025)
18.11
P/S (2025)
1.65
Dividend yield
4.71 %
Net margin
9.10 %
Return on equity (ROE)
9.53 %
Return on assets (ROA)
7.73 %

Vetnostrum Animal Health Co., Ltd. financials

Fiscal year20242025
Revenue1.29 bn TWD1.42 bn TWD
Gross profit440.69 m TWD451.87 m TWD
Operating income170.73 m TWD156.12 m TWD
EBIT170.82 m TWD159.95 m TWD
Net income136.62 m TWD128.85 m TWD
Diluted EPS – continuing operations2.06 TWD1.77 TWD

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Vetnostrum Animal Health Co., Ltd.

Vetnostrum Animal Health Co., Ltd. engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed. It offers antibiotics, hormonal preparations, topical disinfectants, and drugs for anti-inflammatory, deworming, anti-fungal, antiprotozoal, etc; vitamins, minerals, and amino acids for regular supplementary; and non-medicated feed additives for swine, cattle and sheep, poultry, pet, and aquatic animals. The company was founded in 2012 and is based in Hsinchu City, Taiwan. Vetnostrum Animal Health Co., Ltd. operates as a subsidiary of YungShin Global Holding Corporation.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.